MDP — Medexus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- CA$129.38m
- CA$144.11m
- $108.33m
Brief: Medexus Pharmaceuticals Reports Q1 Revenue $16.1 Million
Brief: Medexus Pharma Announces Fourth Quarter Results
Brief: Medexus Pharmaceuticals Announces Normal Course Issuer Bid
Canada Research Roundup: Ero Copper, Frontera Energy, Terago
Brief: Medexus Granted Authorization By Health Canada To Distribute Treosulfan In Canada
Brief: Medexus Pharmaceuticals Enters into Expanded Licensing Agreement for Gliolan in Canada
Brief: Medexus Pharmaceuticals Announces 512% Increase In Revenue To $14.4 Mln For Q3 Fiscal 2019
Brief: Medexus Announces New CEO, Chair Of Board
Brief: Pediapharm Announces Name Change, Consolidation And Debenture Repayment
Brief: Pediapharm Reports Q2 Total Rev Of $3.4 Mln Versus $3.1 Mln
Brief: Pediapharm Announces Transformative Acquisitions And $60 Mln Offering Of Subscription Receipts
Brief: Pediapharm Inc Reports Q1 Revenue of C$3.249 Mln
Brief: Pediapharm Announces Commercial Launch Of Cuvposa In Canada
Brief: Pediapharm Q3 Gross Profit $1.18 Million, Up 32 Pct From Last Yr
Brief: Pediapharm Announces Q2 Revenue $3.1 Mln Versus $1.9 Mln
Brief: Pediapharm receives Health Canada approval for Cuvposa
Brief: Pediapharm completes private placement of units for $5 mln
Brief: Pediapharm reports Q4 net loss of $1.4 mln
Brief: Pediapharm posts Q3 revenue $1.77 mln, up 73 pct